These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24965472)

  • 1. Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.
    Nogales A; Baker SF; Ortiz-Riaño E; Dewhurst S; Topham DJ; Martínez-Sobrido L
    J Virol; 2014 Sep; 88(18):10525-40. PubMed ID: 24965472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rescued influenza A virus with codon deoptimized NS1 gene is attenuated both in vitro and in vivo].
    Luan S; Pan W; Li T; Yang H; Zhang B; Li F; Chen L
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):720-6. PubMed ID: 19670641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes.
    Meng J; Lee S; Hotard AL; Moore ML
    mBio; 2014 Sep; 5(5):e01704-14. PubMed ID: 25249281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.
    Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L
    Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated influenza virus construct with enhanced hemagglutinin protein expression.
    Maamary J; Pica N; Belicha-Villanueva A; Chou YY; Krammer F; Gao Q; García-Sastre A; Palese P
    J Virol; 2012 May; 86(10):5782-90. PubMed ID: 22398291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses.
    Mueller SN; Langley WA; Carnero E; García-Sastre A; Ahmed R
    J Virol; 2010 Feb; 84(4):1847-55. PubMed ID: 19939929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza virus subpopulations: exchange of lethal H5N1 virus NS for H1N1 virus NS triggers de novo generation of defective-interfering particles and enhances interferon-inducing particle efficiency.
    Ngunjiri JM; Buchek GM; Mohni KN; Sekellick MJ; Marcus PI
    J Interferon Cytokine Res; 2013 Mar; 33(3):99-107. PubMed ID: 23215782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.
    Li J; Arévalo MT; Diaz-Arévalo D; Chen Y; Choi JG; Zeng M
    J Control Release; 2015 Jun; 207():70-6. PubMed ID: 25858415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.
    Fan RL; Valkenburg SA; Wong CK; Li OT; Nicholls JM; Rabadan R; Peiris JS; Poon LL
    J Virol; 2015 Nov; 89(21):10762-73. PubMed ID: 26269186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
    Rodriguez L; Blanco-Lobo P; Reilly EC; Maehigashi T; Nogales A; Smith A; Topham DJ; Dewhurst S; Kim B; Martínez-Sobrido L
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31658679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance in Eastern India (2007-2009) revealed reassortment event involving NS and PB1-F2 gene segments among co-circulating influenza A subtypes.
    Sarkar M; Chanda S; Chakrabarti S; Mazumdar J; Ganguly A; Chadha MS; Mishra AC; Chawla-Sarkar M
    Virol J; 2012 Jan; 9():3. PubMed ID: 22217077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
    Steel J; Lowen AC; Pena L; Angel M; Solórzano A; Albrecht R; Perez DR; García-Sastre A; Palese P
    J Virol; 2009 Feb; 83(4):1742-53. PubMed ID: 19073731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets.
    Zhou B; Li Y; Belser JA; Pearce MB; Schmolke M; Subba AX; Shi Z; Zaki SR; Blau DM; García-Sastre A; Tumpey TM; Wentworth DE
    Vaccine; 2010 Nov; 28(50):8015-25. PubMed ID: 20934458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research of recombinant influenza A virus as a vector for Mycoplasma pneumoniae P1a and P30a.
    Yu L; Yongbo W; Shengjun Y; Jia T; Ya X; Guoyang L; Linna M
    Immun Inflamm Dis; 2024 Sep; 12(9):e70021. PubMed ID: 39291404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.